Clicky

ProPhase Labs, Inc.(PRPH)

Description: ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.


Keywords: Zinc Dietary Supplement Health Products Allergy Contract Manufacturing Contract Manufacturing Services Cough Vitamins Over The Counter Drug Common Cold Cosmeceutical Products Upper Respiratory Tract Infection Homeopathy Respiratory Infection Cold Remedy Products Throat Lozenge Upper Respiratory Infection

Home Page: www.prophaselabs.com

PRPH Technical Analysis

711 Stewart Avenue
Garden City, NY 11530
United States
Phone: 215 345 0919


Officers

Name Title
Mr. Ted William Karkus Chairman & CEO
Ms. Monica Brady Chief Accounting Officer
Ms. Alice Lioi Exec. VP & Co-COO
Mr. Jason Karkus Exec. VP & Co-COO
Mr. Sergio Miralles Exec. VP & Chief Information Officer of ProPhase Diagnostics
Mr. Billy Joe White Consultant

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 10.0908
Trailing PE: 4.9624
Price-to-Book MRQ: 2.3894
Price-to-Sales TTM: 1.1351
IPO Date: 1997-01-16
Fiscal Year End: December
Full Time Employees: 129
Back to stocks